GP
DGX icon

GLG Partners’s Quest Diagnostics DGX Stock Holding History

GLG Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$162K Buy
+1,645
New +$156K 0.01% 388
2014
Q3 		– Sell
-13,265
Closed -$779K – 433
2014
Q2 		$779K Buy
+13,265
New +$777K 0.02% 326

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

GLG Partners's DGX Position: Q4 2017 in Review

GLG Partners opened a new position in Quest Diagnostics (DGX) in Q4 2017: 1,645 shares worth $162K. The stake represents 0.01% of the portfolio and ranks #388 among its holdings. This is a return to the name: GLG Partners previously reported a position in DGX as recently as Q2 2014.

GLG Partners first reported a position in DGX in Q2 2014 and has held it in 2 quarters since. The position peaked at $779K in Q2 2014. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • GLG Partners held 1,645 shares of Quest Diagnostics worth $162K as of Q4 2017.
  • Quest Diagnostics was a new GLG Partners position in Q4 2017.
  • Quest Diagnostics made up 0.01% of GLG Partners's portfolio in Q4 2017, its #388 holding.
  • GLG Partners first reported a position in Quest Diagnostics in Q2 2014 and has held it in 2 quarters since.
  • GLG Partners's Quest Diagnostics position peaked at $779K in Q2 2014.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.